EN DE

Centene Corp (CNC) Fair Value & Analysis

Healthcare · US · Market cap $32.9B · ISIN US15135B1017

What is Centene Corp really worth?

CC Centene Corp logo Centene Corp CNC · US
Price$68.02
Fair Value$111.96
Upside+64.6%
Quality62/100

A solid business, trading 39% below our fair value of $111.96.

Watch Centene Corp for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free

Strengths

Moderate debt · generates free cash flow
Ranks above peers (9/14)

Risks

!Mixed Growth (revenue 5y +11.9 %/yr)
!Loss-making · -3.6% net margin
!Narrow moat 24/100
!Evidence only medium, so the estimate is less certain
!Weak on future: 26 out of 100
!Weak on dividend: 6 out of 100
Evidence: Medium Range $77.83 – $146.08

Fair value as of: Aug 30, 2026

From 9 valuation models · updated 6 days ago

Share price +6.2% over the past month.

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

What matters now

  • The price is below even our cautious bear case ($77.83). The market is more pessimistic than our downside scenario.
  • Solid quality (62/100) at a price below fair value, the discount is the argument here, not the business quality.
  • A fairly wide model range ($77.83 to $146.08) leaves room in how you read the outcome.

Price vs Fair Value (5 years)

$97.22 $25.21 Fair Value $111.96 Jun 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 30, 2026.

How to read this chart

60‑month range $25.21 – $97.22 · fair‑value band $77.83 – $146.08 · the $68.02 price screens below the $111.96 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 30, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Centene Corp (CNC) currently trades at $68.02, while our model-based Fair Value estimate is $111.96, implying the stock looks roughly 39.2% undervalued today. The Quality Score stands at 62/100 (solid quality), in the Healthcare sector. Bull case: the DCF Models group reads highest at a median of $232.83 per share, and 6 of the 9 models we run sit above the $68.02 price. Bear case: the Asset-Based group reads lowest at $27.07, and 3 of the 9 models stay below the price. Evidence for this calculation is medium.

Over the trailing twelve months, Centene Corp generated revenue of $178B at a net margin of −3.6%. Revenue grew 5.1% year over year. It earns a return on equity of −26.0%. Net debt stands at $889M. Fundamentals as of Aug 30, 2026

Our scenario range runs from $77.83 (bear case) to $146.08 (bull case); at $68.02, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high and 171% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at −26% fair-value upside, at 65%, CNC screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
FCF DCF $148.37 $232.83 $501.81 75
Growth DCF $139.61 $258.76 $499.59 74
5Y Revenue Exit $105.84 $178.89 $331.48 69
All 9 models by family
DCF Models
FCF DCF $148.37 $232.83 $501.81 75
5Y Revenue Exit $105.84 $178.89 $331.48 69
10Y Revenue Exit $116.49 $246.25 $326.20 66
Dividend Discount
Gordon GGM $1.64 $3.40 $5.40 66
DDM Multi-Stage $1.64 $2.87 $3.57 67
Multiples
EV/Revenue $80.72 $114.84 $148.97 53
Asset-Based
NCAV (Graham) $20.20 $27.07 $40.41 54
Growth DCF
Growth DCF $139.61 $258.76 $499.59 74
Rev-Margin DCF $106.41 $204.53 $388.93 69

Widest divergence: DCF Models ($232.83) versus Dividend Discount ($2.87). Highest evidence: FCF DCF (75).

Notify me when CNC reaches fair value

Put CNC on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Free, no payment details. Unsubscribe anytime in one click.

Key figures & financial health

P/S ratio 0.17 TTM
EPS (TTM) $−13.05
Dividend yield 0.3%
Net margin −3.4% FY2025
Return on equity −26.0% TTM
Return on assets (EBIT) 0.3% avg 5y
More key figures
Profitability
Operating margin 5.1% TTM
Growth
Revenue (TTM) $178B TTM
Revenue growth (YoY) +5.1% 3y avg +10.5%
EPS growth (YoY) +18.3%
Balance sheet & cash flow
Free cash flow $4.3B FY2025
Net debt $889M FY2025 · ≈ 0.2 yrs of FCF

Figures from reported company fundamentals · as of Aug 30, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 62/100

Of which business quality 60 · Market factors (momentum, volatility) 76

Profitability 31
Margins and returns on capital today
Quality Growth 50
Are margins and returns improving?
Cashflow 43
Earnings quality: real cash, not paper profit
Fin. Strength 64
Balance sheet, leverage, solvency risk
Investment 99
Disciplined investing over empire-building
Low Volatility 40
Calm price path (market factor)
Momentum 87
Price trend over the last 3–12 months (market factor)
52W Momentum 99
Distance to the 52-week high (market factor)
Net Issuance 100
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.

About the company

Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other.

Full company description

Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Centene Corp reported revenue of $195B in FY2025 versus $126B in FY2021, a compound +11.5%/yr. Reported net income was −$6.7B in FY2025.

Growth Quality 57/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
$195B
Latest YoY
+19.4%
Avg. revenue growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+10.5%
Avg. revenue growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+11.9%
Avg. revenue growth/yr (26Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+30.3%
Value creation/yr We only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Revenue +11.5%/yr
FY21 $126B
FY22 $145B
FY23 $154B
FY24 $163B
FY25 $195B
Net income
FY21 $1.3B
FY22 $1.2B
FY23 $2.7B
FY24 $3.3B
FY25 −$6.7B
Character of growth · EPS growth decomposed (2014-2025) +17.2 % p.a.
Revenue per share +13.9 %

of which total revenue +23.3 % · buybacks/dilution −7.7 %

EBIT margin −5.2 %
Tax rate +4.8 %
Residual (interest, one-offs) +3.6 %

Annual growth per factor. These are factors, not summands: multiplied they give the EPS growth rate, added they do not quite. Start and end points are 3-year averages (details on hover).

Watch CNC: get an alert when its fair value changes →

Share or link this analysis · shared 8×
𝕏 Post WhatsApp LinkedIn Reddit
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Centene Corp Fair Value". https://www.fairvalue-calculator.com/stock/CNC

Recent news

External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.

Peer Group

Healthcare Plans · 15 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 62 · Above median
Fair Value upside +65% · Top 25%
Return on assets 1% · Bottom 25%
Net margin (TTM) −4% · Bottom 25%
Operating margin (TTM) 5% · Above median
Revenue growth 5% · Above median
Dividend yield (TTM) 0.3% · Bottom 25%
Debt / equity 0.87× · Higher than 75% of peers

Valuation Multiples vs Healthcare Plans median · lower = cheaper

P/B 1.65× · Cheaper than 75% of peers
P/S (TTM) 0.18× · Cheaper than 75% of peers
P/FCF 7.6× · Cheaper than median
EV/EBITDA 11.1× · Cheaper than 75% of peers
PEG 1.32× · Cheaper than median

Strength profile in five axes (Snowflake)

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE100 · sector 33
FUTURE26 · sector 23
PAST0 · sector 30
HEALTH57 · sector 65
DIVIDEND6 · sector 34

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Healthcare Plans stocks, each showing price versus our Fair Value estimate (as of Aug 30, 2026).

Stock Price Fair Value vs Fair Value
UnitedHealth Group UNH $395.05 $292.06 −26%
CVS Health Corporation CVS $93.06 $42.25 −55%
Elevance Health, Inc ELV $399.14 $426.53 +7%
The Cigna Group CI $276.08 $495.42 +79%
Humana Inc HUM $385.54 $126.42 −67%
Molina Healthcare, Inc MOH $203.06 $199.31 −2%
Oscar Health, Inc OSCR $30.93 $61.86 +100%
Alignment Healthcare, Inc ALHC $13.52 $2.37 −82%
Progyny, Inc PGNY $25.65 $16.44 −36%
Medi Assist Healthcare Services Limited MEDIASSIST ₹346.80 ₹226.12 −35%

Compare Centene Corp with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screener Filter by region, size and sector Compare tool Two stocks side by side Extrinsic Value Calculator (Options) Splits an option premium into intrinsic and extrinsic (time) value. Peter Lynch Fair Value Formula & Calculator Apply Peter Lynch's fair value formula in seconds: fair P/E ≈ earnings growth (+ dividend) - free, with formula and example.

Frequently asked questions

Is Centene Corp (CNC) overvalued or undervalued?
As of Aug 30, 2026, our model estimates a fair value of $111.96 versus a price of $68.02, about +65% upside (undervalued).
What is the fair value of CNC?
Our model-based fair value for Centene Corp is $111.96 (as of Aug 30, 2026), built from audited fundamentals. The current price: $68.02.
What is the quality score of CNC?
Centene Corp has a Quality Score of 62/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Centene Corp (CNC)?
Centene Corp reported trailing-twelve-month revenue of about $178B (latest available figure, as of Aug 30, 2026).
What is the net profit margin of CNC?
The net profit margin of Centene Corp is about −3.6%, meaning it is currently running at a net loss. Based on the latest reported figures.
Does Centene Corp pay a dividend?
Centene Corp currently shows a dividend yield of about 0.30% relative to its recent price (as of Aug 30, 2026).
Free · no account needed

Watch Centene Corp in the live analysis

One click puts Centene Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.